Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases

被引:61
作者
Siva, Kavitha [1 ]
Covello, Giuseppina [1 ]
Denti, Michela A. [1 ,2 ]
机构
[1] Univ Trento, Ctr Integrat Biol CIBIO, I-38123 Trento, Italy
[2] CNR, Inst Neurosci, Padua, Italy
关键词
RESTORES DYSTROPHIN EXPRESSION; AMYLOID PRECURSOR PROTEIN; SPINAL MUSCULAR-ATROPHY; PEPTIDE NUCLEIC-ACID; PELIZAEUS-MERZBACHER-DISEASE; RECEPTOR-ALPHA CHAIN; BLOOD-BRAIN-BARRIER; BETA-TRACE PROTEIN; LONG-TERM RESCUE; MDX MICE;
D O I
10.1089/nat.2013.0461
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative splicing is an important regulator of the transcriptome. However, mutations may cause alteration of splicing patterns, which in turn leads to disease. During the past 10 years, exon skipping has been looked upon as a powerful tool for correction of missplicing in disease and progress has been made towards clinical trials. In this review, we discuss the use of antisense oligonucleotides to correct splicing defects through exon skipping, with a special focus on diseases affecting the nervous system, and the latest stage achieved in its progress.
引用
收藏
页码:69 / 86
页数:18
相关论文
共 133 条
[71]   Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy [J].
Lee, Yi ;
El Andaloussi, Samir ;
Wood, Matthew J. A. .
HUMAN MOLECULAR GENETICS, 2012, 21 :R125-R134
[72]   Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo [J].
Li, Yong-Fu ;
Morcos, Paul A. .
BIOCONJUGATE CHEMISTRY, 2008, 19 (07) :1464-1470
[73]   Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles [J].
Lu, QL ;
Rabinowitz, A ;
Chen, YC ;
Yokota, T ;
Yin, HF ;
Alter, J ;
Jadoon, A ;
Bou-Gharios, G ;
Partridge, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (01) :198-203
[74]   Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse [J].
Lu, QL ;
Mann, CJ ;
Lou, F ;
Bou-Gharios, G ;
Morris, GE ;
Xue, SA ;
Fletcher, S ;
Partridge, TA ;
Wilton, SD .
NATURE MEDICINE, 2003, 9 (08) :1009-1014
[75]   Molecular analysis of 30 Niemann-Pick type C patients from Spain [J].
Macias-Vidal, J. ;
Rodriguez-Pascau, L. ;
Sanchez-Olle, G. ;
Lluch, M. ;
Vilageliu, L. ;
Grinberg, D. ;
Coll, M. J. .
CLINICAL GENETICS, 2011, 80 (01) :39-49
[76]   Megalencephalic leukoencephalopathy with subcortical cysts type 1 (MLC1) due to a homozygous deep intronic splicing mutation (c.895-226T>G) abrogated in vitro using an antisense morpholino oligonucleotide [J].
Mancini, Cecilia ;
Vaula, Giovanna ;
Scalzitti, Laura ;
Cavalieri, Simona ;
Bertini, Enrico ;
Aiello, Chiara ;
Lucchini, Cinzia ;
Gatti, Richard A. ;
Brussino, Alessandro ;
Brusco, Alfredo .
NEUROGENETICS, 2012, 13 (03) :205-214
[77]   2′-Carbohydrate modifications in antisense oligonucleotide therapy:: importance of conformation, configuration and conjugation [J].
Manoharan, M .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :117-130
[78]  
MASSERINI M., 2013, ISRN BIOCH, DOI 10.1155/2013/238428
[79]   Understanding alternative splicing: Towards a cellular code [J].
Matlin, AJ ;
Clark, F ;
Smith, CWJ .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (05) :386-398
[80]   Niemann-Pick Disease Type C: Implications for Sedation and Anesthesia for Diagnostic Procedures [J].
Miao, Ning ;
Lu, Xiaowei ;
O'Grady, Naomi P. ;
Yanjanin, Nicole ;
Porter, Forbes D. ;
Quezado, Zenaide M. N. .
JOURNAL OF CHILD NEUROLOGY, 2012, 27 (12) :1541-1546